NCT03849313 Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab) Status COMPLETED Phase PHASE1
NCT03823391 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT03739853 Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial Status COMPLETED Phase PHASE4
NCT03737708 A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE4
NCT03662919 One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study Status COMPLETED Phase N/A
NCT03619876 Effects of Abatacept on Myocarditis in Rheumatoid Arthritis Status TERMINATED Phase PHASE4
NCT03561649 Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA Status COMPLETED Phase NA
NCT03505008 Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan Status COMPLETED Phase PHASE4
NCT03414502 Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response Status RECRUITING Phase PHASE3
NCT03412747 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03357939 Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects Status COMPLETED Phase PHASE1
NCT03316781 Study of Efficacy and Safety of HLX03 in Subjects With Moderate to Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03311464 A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan Status COMPLETED Phase PHASE3
NCT03273192 A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects Status COMPLETED Phase PHASE1
NCT03261102 TDM Guided Early Optimization of ADAL in Crohn's Disease Status ACTIVE_NOT_RECRUITING Phase NA
NCT03248531 A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. Status COMPLETED Phase PHASE2
NCT03172325 Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA Status COMPLETED Phase PHASE3